US Patent Issued to BIOGEN MA on March 3 for "Spirocyclic O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors" (Massachusetts Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,565,504, issued on March 3, was assigned to BIOGEN MA INC. (Cambridge, Mass.).

"Spirocyclic O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors" was invented by Nathan Genung (Charlestown, Mass.), Kevin M. Guckian (Northborough, Mass.), Lei Zhang (Westford, Mass.), Zhili Xin (Cambridge, Mass.), Jeffrey Vessels (Marlborough, Mass.) and Ryan Gianatassio (Everett, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are compounds represented by formula (I) or formula (Ia) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising the same and methods of preparing and using the same. The variables ...